Application 214665

Type
NDA
Sponsor
AMGEN INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LUMAKRASSOTORASIBTABLET;ORAL120MGNoNo
002LUMAKRASSOTORASIBTABLET;ORAL320MGYesYes
003LUMAKRASSOTORASIBTABLET;ORAL240MGYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
55513-488LUMAKRASsotorasibAmgen IncNDACurrent
55513-488LUMAKRASsotorasibAmgen IncNDACurrent
55513-488LUMAKRASsotorasibAmgen IncNDACurrent
55513-488LUMAKRASsotorasibAmgen IncNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
82805SUPPL 2025-07-11
80871SUPPL 2025-02-24
80859SUPPL 2025-02-24
80002SUPPL 2024-10-28
79794SUPPL 2024-10-01
74058SUPPL 2023-04-25
74056SUPPL 2023-04-25
73807SUPPL 2023-03-20
73270SUPPL2023-01-23
73265SUPPL2023-01-23
72672SUPPL2022-11-23
72668SUPPL2022-11-22
67896ORIG2021-06-24
67636ORIG2021-06-01
67623ORIG2021-05-28